UMB, Terran Biosciences forge exclusive licensing deal

Terran Biosciences Inc. has entered into an agreement with the University of Maryland, Baltimore for a worldwide exclusive license to develop and commercialize a portfolio of UMB’s patents and data to support a novel approach to the treatment of neurological and psychiatric illnesses with psychedelic therapeutics. Terms of the deal were not disclosed.